Healthcare Industry News:  Tissue Welding Technology 

Devices Distribution

 News Release - July 22, 2008

Starion Instruments Signs Distribution Agreement With Datascope for Tissue Welding Technology

Agreement Reinforces Starion's Leadership Position in the Cardiac Marketplace

SUNNYVALE, Calif., July 22 (HSMN NewsFeed) -- Starion Instruments, a leading surgical device company, today announced a non-exclusive distribution agreement with Datascope Corp. to integrate Starion's patented Tissue Welding Technology into Datascope's procedural kits for endoscopic saphenous vein and radial artery harvesting.

The driving force behind this new agreement was Datascope's customer demand for Starion's Tissue Welding Technology, which uses direct heat and pressure to simultaneously seal and divide soft tissue and vessels, reducing the risk of inadvertent collateral damage. Datascope customers now have access to Starion's STLS 23 and STLS 35 Thermal Ligating Shears for unparalleled effectiveness, reliability and versatility during endoscopic cardiac procedures.

Dr. Antonino Laudani, chief operating officer of Datascope, said, "We are continuously looking for opportunities to meet customer needs in the cardiovascular market. Starion's distribution agreement allows us to broaden our endoscopic vessel harvesting range, and therefore contributes to our global growth strategy."

"Demand for our products is growing as surgeons and patients experience the clinical benefits of Tissue Welding Technology over traditional seal and cut modalities," said Kirt Kirtland, president and chief executive officer of Starion Instruments. "This new agreement reflects this increased demand and enables us to strengthen our leadership position in the cardiac marketplace."

About Starion Instruments

Starion develops advanced surgical devices that enhance performance, minimize risk and improve patient outcomes. Starion's instruments employ a patented Tissue Welding Technology that seals and divides soft tissue with only focused heat and pressure. Known for their effectiveness, reliability and versatility, Starion's products are used worldwide for open and endoscopic cardiac, gynecology, general surgery, otolaryngology and urology procedures. For more information, visit

About Datascope Corp.

Datascope Corp. is the global leader of intra-aortic balloon counterpulsation and a diversified medical device company that develops, manufactures and markets proprietary products for clinical health care markets in interventional cardiology and radiology, cardiovascular and vascular surgery, and critical care. The Company's products are sold throughout the world through direct sales representatives and independent distributors. Founded in 1964, Datascope is headquartered in Montvale, New Jersey. For news releases, webcasts and other Company information please visit Datascope's website,

Source: Starion Instruments

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.